Mycobacterium marinum: an increasingly common opportunistic infection in patients on infliximab

Am J Gastroenterol. 2012 Aug;107(8):1268-9. doi: 10.1038/ajg.2012.118.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Crohn Disease / drug therapy*
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / therapeutic use*
  • Infliximab
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous / etiology*
  • Mycobacterium Infections, Nontuberculous / immunology*
  • Mycobacterium marinum*
  • Opportunistic Infections*
  • Skin Diseases, Bacterial / immunology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Infliximab